Point72 Asset Management
WST icon

Point72 Asset Management’s West Pharmaceutical WST Stock Holding History

Point72 Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,200
Closed -$330K – 4602
2025
Q4 		$330K Buy
+1,200
New +$328K ﹤0.01% 3439
2024
Q2 		– Sell
-20,000
Closed -$7.91M – 2521
2024
Q1 		$7.91M Buy
+20,000
New +$7.4M 0.02% 803

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's WST Position: Q1 2026 in Review

Point72 Asset Management reduced its West Pharmaceutical (WST) stake by 32% in Q1 2026, selling an estimated $18.8M and leaving 159,350 shares worth $39.9M. The position accounts for 0.05% of the portfolio, ranked #468.

Point72 Asset Management first reported a position in WST in Q2 2019 and has held it in 21 quarters since. The position peaked at $173M in Q3 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Point72 Asset Management held 159,350 shares of West Pharmaceutical worth $39.9M as of Q1 2026.
  • Point72 Asset Management sold 75,687 West Pharmaceutical shares in Q1 2026, an estimated $18.8M.
  • West Pharmaceutical made up 0.05% of Point72 Asset Management's portfolio in Q1 2026, its #468 holding.
  • Point72 Asset Management first reported a position in West Pharmaceutical in Q2 2019 and has held it in 21 quarters since.
  • Point72 Asset Management's West Pharmaceutical position peaked at $173M in Q3 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.